Neoadjuvant Immuno-Chemotherapy: A New Perspective for Stage III NSCLC?
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Surgery"
DOI: 10.3389/fsurg.2022.843987
Abstract: Background Stage III Non-small cell lung cancer (NSCLC) is a heterogenous disease with novel treatment options. Recently, immunotherapy has attracted a lot of attention for advanced NSCLC. Objective The objective of our study was to… read more here.
Keywords: stage iii; immuno chemotherapy; neoadjuvant immuno; stage ... See more keywords